BlackRock acquired 25.9M Agilent Technologies shares worth $3.58B. That's 0.05% of their equity portfolio (279th largest holding). The investor owns 9.36% of the outstanding Agilent Technologies stock. The first Agilent Technologies trade was made in Q4 2020. Since then BlackRock bought shares eight more times and sold shares on nine occasions. The stake costed the investor $3.02B, netting the investor a gain of 18% so far.
Agilent (A) unveils its new ProteoAnalyzer system in a bid to strengthen its Diagnostics and Genomics Group segment.
Agilent Technologies said on Monday it will acquire contract drug manufacturer Biovectra for $925 million to expand its portfolio of services offered to biot...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent has signed a definitive agreement to acquire BIOVECTRA, a leading contract development and manufacturing organi...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) will release financial results for the third quarter of fiscal year 2024 after the ...